Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 487508

The clinical revalence of p53 isoforms in ovarian cancer


Hofstetter, Gerda; Concin, Nicole; Berger, Astrid; Fiegl, Heidi; Slade, Neda; Zorić, Arijana; Tong, D; Holzer, Barbara; Schuster, E.; Wolf, Andrea et al.
The clinical revalence of p53 isoforms in ovarian cancer // p53 isoforms through evolution: from identification to biological function
Lyon: International Agency for Research on Cancer (IARC), 2010. str. 44-44 (predavanje, nije recenziran, sažetak, znanstveni)


CROSBI ID: 487508 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
The clinical revalence of p53 isoforms in ovarian cancer

Autori
Hofstetter, Gerda ; Concin, Nicole ; Berger, Astrid ; Fiegl, Heidi ; Slade, Neda ; Zorić, Arijana ; Tong, D ; Holzer, Barbara ; Schuster, E. ; Wolf, Andrea ; Marth, Christian ; Zeimet, Alain ; Zeillinger, Robert

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni

Izvornik
P53 isoforms through evolution: from identification to biological function / - Lyon : International Agency for Research on Cancer (IARC), 2010, 44-44

Skup
1st International p53 Isoforms Meeting

Mjesto i datum
Lyon, Francuska, 2010

Vrsta sudjelovanja
Predavanje

Vrsta recenzije
Nije recenziran

Ključne riječi
p53 splicing variant ; p73 ; ovarian carcinoma

Sažetak
P53 splice variants were present in 18 of 34 ovarian cancer cell lines (52.9%) and 134 of 245 primary ovarian cancers (54.7%). p53delta expression was associated with impaired response to primary platinum-based chemotherapy (P=0.032). Also, p53delta expression constituted an independent prognostic marker for recurrence-free and overall survival (hazard ratio 1.854, 95% confidence interval 1.121–3.065, P=0.016 ; and hazard ratio 1.937, 95% confidence interval 1.177–3.186, P=0.009, respectively). p53beta expression was associated with adverse clinicopathologic markers, that is, serous and poorly differentiated cancers (P=0.002 and P=0.008, respectively), and correlated with worse recurrence-free survival in patients exhibiting functionally active p53 (P=0.049).

Izvorni jezik
Engleski

Znanstvena područja
Biologija, Temeljne medicinske znanosti



POVEZANOST RADA


Projekti:
098-0982464-2391 - Uloga mreže proteina p53/p73 u sarkomima mekih tkiva čovjeka (Slade, Neda, MZOS ) ( CroRIS)

Ustanove:
Institut "Ruđer Bošković", Zagreb

Profili:

Avatar Url Neda Slade (autor)


Citiraj ovu publikaciju:

Hofstetter, Gerda; Concin, Nicole; Berger, Astrid; Fiegl, Heidi; Slade, Neda; Zorić, Arijana; Tong, D; Holzer, Barbara; Schuster, E.; Wolf, Andrea et al.
The clinical revalence of p53 isoforms in ovarian cancer // p53 isoforms through evolution: from identification to biological function
Lyon: International Agency for Research on Cancer (IARC), 2010. str. 44-44 (predavanje, nije recenziran, sažetak, znanstveni)
Hofstetter, G., Concin, N., Berger, A., Fiegl, H., Slade, N., Zorić, A., Tong, D., Holzer, B., Schuster, E. & Wolf, A. (2010) The clinical revalence of p53 isoforms in ovarian cancer. U: p53 isoforms through evolution: from identification to biological function.
@article{article, author = {Hofstetter, Gerda and Concin, Nicole and Berger, Astrid and Fiegl, Heidi and Slade, Neda and Zori\'{c}, Arijana and Tong, D and Holzer, Barbara and Schuster, E. and Wolf, Andrea and Marth, Christian and Zeimet, Alain and Zeillinger, Robert}, year = {2010}, pages = {44-44}, keywords = {p53 splicing variant, p73, ovarian carcinoma}, title = {The clinical revalence of p53 isoforms in ovarian cancer}, keyword = {p53 splicing variant, p73, ovarian carcinoma}, publisher = {International Agency for Research on Cancer (IARC)}, publisherplace = {Lyon, Francuska} }
@article{article, author = {Hofstetter, Gerda and Concin, Nicole and Berger, Astrid and Fiegl, Heidi and Slade, Neda and Zori\'{c}, Arijana and Tong, D and Holzer, Barbara and Schuster, E. and Wolf, Andrea and Marth, Christian and Zeimet, Alain and Zeillinger, Robert}, year = {2010}, pages = {44-44}, keywords = {p53 splicing variant, p73, ovarian carcinoma}, title = {The clinical revalence of p53 isoforms in ovarian cancer}, keyword = {p53 splicing variant, p73, ovarian carcinoma}, publisher = {International Agency for Research on Cancer (IARC)}, publisherplace = {Lyon, Francuska} }




Contrast
Increase Font
Decrease Font
Dyslexic Font